6-(bromomethyl)pteridine-2,4-diamine (hydrobromide)
Catalog No.: BK00PZ
CAS.RN：52853-40-4
Molecular Formula: C7H8Br2N6
Molecular Weight: 335.99 g/mol
Purity: NLT 98%
Intermediates of Pralatrexate
| Catalog No. | Product Name | CAS |
|---|---|---|
| BA20Q7 | Pralatrexate API | 146464-95-1 |
| BK8PF0 | 6-Pteridinepropanoic acid, 2,4-diamino-α-(4-carboxyphenyl)-α-2-propyn-1-yl-, hydrochloride | 1497287-42-9 |
| BK89U0 | 6-Pteridinepropanoic acid, 2,4-diamino-α-(4-carboxyphenyl)-α-2-propyn-1-yl- | 146464-92-8 |
| BK14W3 | Dimethyl homoterephthalate | 52787-14-1 |
| BK6A5J | 6-Pteridinepropanoic acid, 2,4-diamino-α-[4-(methoxycarbonyl)phenyl]-α-2-propyn-1-yl-, methyl ester, hydrobromide | 1548618-47-8 |
| BK08P3 | 4-(1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl)benzoic acid | 146464-93-9 |
| BK12U4 | Benzeneacetic acid, 4-(methoxycarbonyl)-α-2-propyn-1-yl-, methyl ester | 146464-90-6 |
| BK00PZ | 6-(bromomethyl)pteridine-2,4-diamine (hydrobromide) | 52853-40-4 |
Products are offered for research, development, or industrial use only.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
